Influenza Outbreaks: Predicting Strains, Protecting Yourself, and WHO Guidelines

Preview this chapter:

Influenza Outbreaks: Predicting Strains, Protecting Yourself, and WHO Guidelines, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815313475/chapter-3-1.gif

Influenza represents a significant global viral threat, infecting millions annually and leading to hundreds of thousands of deaths. Intermittent influenza pandemics carry substantial risks of illness and death. Belonging to the Orthomyxoviridae family, the influenza virus possesses a segmented, negative-strand RNA genome. The widespread presence of influenza in avian and mammalian species, combined with its segmented genome, creates ongoing possibilities for reassortment events that may result in cross-species transmission. Yearly seasonal influenza outbreaks occur in temperate regions, typically causing common respiratory symptoms like cough, fever, muscle aches, and headache. Pneumonia stands out as the most frequent severe complication, particularly dangerous for young children and older individuals. Antiviral medications are available for influenza treatment and prevention in high-risk groups. While vaccines exist for seasonal influenza prevention, their effectiveness is not ideal. A deeper understanding of early immune responses to influenza is likely to aid in the development of improved influenza vaccines offering broad and lasting immunity.